EP0786999A4 - Combination method for acne treatment - Google Patents

Combination method for acne treatment

Info

Publication number
EP0786999A4
EP0786999A4 EP95936349A EP95936349A EP0786999A4 EP 0786999 A4 EP0786999 A4 EP 0786999A4 EP 95936349 A EP95936349 A EP 95936349A EP 95936349 A EP95936349 A EP 95936349A EP 0786999 A4 EP0786999 A4 EP 0786999A4
Authority
EP
European Patent Office
Prior art keywords
combination method
acne treatment
acne
treatment
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95936349A
Other languages
German (de)
French (fr)
Other versions
EP0786999A1 (en
Inventor
Joanne Waldstreicher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0786999A1 publication Critical patent/EP0786999A1/en
Publication of EP0786999A4 publication Critical patent/EP0786999A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP95936349A 1994-10-21 1995-10-17 Combination method for acne treatment Withdrawn EP0786999A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32717194A 1994-10-21 1994-10-21
US327171 1994-10-21
PCT/US1995/013305 WO1996012487A1 (en) 1994-10-21 1995-10-17 Combination method for acne treatment

Publications (2)

Publication Number Publication Date
EP0786999A1 EP0786999A1 (en) 1997-08-06
EP0786999A4 true EP0786999A4 (en) 1999-01-20

Family

ID=23275460

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95936349A Withdrawn EP0786999A4 (en) 1994-10-21 1995-10-17 Combination method for acne treatment

Country Status (5)

Country Link
EP (1) EP0786999A4 (en)
JP (1) JPH10508586A (en)
AU (1) AU694576B2 (en)
CA (1) CA2199979A1 (en)
WO (1) WO1996012487A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4526247B2 (en) * 2002-07-08 2010-08-18 第一三共株式会社 Oral cephalosporins
US20050136015A1 (en) * 2003-12-17 2005-06-23 McKie Derrick B. Topical use of halosalicylic acid derivatives
EP2144608B1 (en) * 2007-05-14 2017-01-25 Sytheon Ltd. Sunscreen compositions and methods
CN107708665B (en) 2015-03-23 2022-07-22 贝尔生物制药有限公司 Pharmaceutical tetracycline compositions for dermatological use
IT201700060645A1 (en) * 2017-06-01 2018-12-01 Abiogen Pharma Spa USE OF XIBORNOL AS AN ACTIVE AGENT IN ACNE VOLGARE TREATMENT

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007586A1 (en) * 1990-10-31 1992-05-14 Beecham Group Plc Topical composition with retinoid penetration enhancer
WO1994020104A1 (en) * 1993-03-12 1994-09-15 Merck & Co, Inc. 15-substituted 4-azasteroids
WO1995011254A1 (en) * 1993-10-21 1995-04-27 Merck & Co., Inc. 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
WO1995013077A1 (en) * 1993-11-12 1995-05-18 Merck & Co., Inc. 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-3-ONES AS SELECTIVE 5α-REDUCTASE 1 INHIBITORS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
WO1993023039A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. Substituted 4-aza-5a-androstan-ones as 5a-reductase inhibitors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007586A1 (en) * 1990-10-31 1992-05-14 Beecham Group Plc Topical composition with retinoid penetration enhancer
WO1994020104A1 (en) * 1993-03-12 1994-09-15 Merck & Co, Inc. 15-substituted 4-azasteroids
WO1995011254A1 (en) * 1993-10-21 1995-04-27 Merck & Co., Inc. 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
WO1995013077A1 (en) * 1993-11-12 1995-05-18 Merck & Co., Inc. 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-3-ONES AS SELECTIVE 5α-REDUCTASE 1 INHIBITORS

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Pschyrembel Klinisches Wörterbuch", 1990, WALTER DE GRUYTER, BERLIN NEW YORK, XP002081095 *
"Rote Liste", 1991, EDITIO CANTOR, AULENDORF/WÜRTT., XP002065463 *
"Rote Liste", 1994, EDITIO CANTOR, AULENDORF/WÜRTT., XP002081096 *
"Rote Liste", 1994, EDITIO CANTOR, AULENDORF/WÜRTT., XP002081097 *
"The Merck Index, 11th ed.", 1989, MERCK & CO., INC, RAHWAY, N.J. (USA), XP002081094 *
See also references of WO9612487A1 *

Also Published As

Publication number Publication date
CA2199979A1 (en) 1996-05-02
EP0786999A1 (en) 1997-08-06
AU694576B2 (en) 1998-07-23
JPH10508586A (en) 1998-08-25
AU3833695A (en) 1996-05-15
WO1996012487A1 (en) 1996-05-02

Similar Documents

Publication Publication Date Title
EP0792371A4 (en) Combination method for acne treatment
IL126203A0 (en) Method for treating pain
EP0906104A4 (en) Method for treating pain
ZA951948B (en) Apparatus for an efficient photodynamic treatment
IL160505A0 (en) Method and apparatus for acne treatment
SG50018A1 (en) Method for developing treatment
AU4017395A (en) Method for treating anxiety
IL126759A0 (en) Method for treating inflammation
GB9605828D0 (en) Treatment method
IL126064A0 (en) Method for treating pain
GB2289946B (en) Method
PL328964A1 (en) Acne treating method
IL124786A0 (en) Method for treating pain
EP0786999A4 (en) Combination method for acne treatment
GB9714841D0 (en) Treatment method
AU4017195A (en) Method for treating anxiety
AU3662895A (en) Method for treating animals
KR970006505B1 (en) Waste treatment method
IL119272A0 (en) Method for treating acne
GB9412134D0 (en) Treatment method
GB9417504D0 (en) Treatment method
GB9412456D0 (en) Treatment method
GB9401566D0 (en) Method
GB9614743D0 (en) Treatment method
GB9600610D0 (en) Treatment method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970521

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19981203

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20001103

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010314